ライフサイエンスコーパス: Cryptococcus neoformans

1 for virulence of the human pathogenic fungus Cryptococcus neoformans.

2 th a similar function in the related species Cryptococcus neoformans.

3 mall-RNA biogenesis in the pathogenic fungus Cryptococcus neoformans.

4 ual development of the human fungal pathogen Cryptococcus neoformans.

5 Candida species, Aspergillus fumigatus, and Cryptococcus neoformans.

6 ntainment following pulmonary challenge with Cryptococcus neoformans.

7 C57BL/6 mice after pulmonary infection with Cryptococcus neoformans.

8 hose for the pathogens, Candida albicans and Cryptococcus neoformans.

9 involved in polysaccharide O-acetylation in Cryptococcus neoformans.

10 haromyces cerevisiae, Malassezia furfur, and Cryptococcus neoformans.

11 illness caused by the opportunistic pathogen Cryptococcus neoformans.

12 ts (MC) arising from phenotypic switching of Cryptococcus neoformans.

13 transgene array in the human fungal pathogen Cryptococcus neoformans.

14 prolongs the survival of mice infected with Cryptococcus neoformans.

15 ghest prevalence of coinfection with HIV and Cryptococcus neoformans.

16 e host survival of the human fungal pathogen Cryptococcus neoformans.

17 sponse to infection with the fungal pathogen Cryptococcus neoformans.

18 tic cells (DC) during their interaction with Cryptococcus neoformans.

19 ssociated trait by the human fungal pathogen Cryptococcus neoformans.

20 nt role in protection against infection with Cryptococcus neoformans.

21 osis induced by intratracheal inoculation of Cryptococcus neoformans.

22 T cell responses to the opportunistic fungus Cryptococcus neoformans.

23 l time of mice infected intracerebrally with Cryptococcus neoformans.

24 nt role in immunity to the pathogenic fungus Cryptococcus neoformans.

25 ergillus isolates, 110 Candida isolates, and Cryptococcus neoformans.

26 Rho1 guanyl-nucleotide exchange factor) from Cryptococcus neoformans.

27 n their susceptibility to a fungal pathogen, Cryptococcus neoformans.

28 e major factor required for the virulence of Cryptococcus neoformans.

29 nd separation in the human pathogenic fungus Cryptococcus neoformans.

30 olog, Gib2, from the human pathogenic fungus Cryptococcus neoformans.

31 or many pathogenic fungal species, including Cryptococcus neoformans.

32 nsing pathway in the human pathogenic fungus Cryptococcus neoformans.

33 t regulates virulence in the fungal pathogen Cryptococcus neoformans.

34 IP5/IP7, which is essential for virulence of Cryptococcus neoformans.

35 central role in regulating the virulence of Cryptococcus neoformans.

36 d with the distantly related fungal pathogen Cryptococcus neoformans.

37 of H3K27 methylation (H3K27me) in the yeast Cryptococcus neoformans.

38 nown whether such an association exists with Cryptococcus neoformans.

39 genes in bacteria [16], and mating events in Cryptococcus neoformans[14, 17].

40 cosis following intratracheal inoculation of Cryptococcus neoformans 24067.

41 a spp., 146 from 9 Aspergillus spp., 84 from Cryptococcus neoformans, 40 from 23 other mold species,

42 nfected with a moderately virulent strain of Cryptococcus neoformans (52D), which resulted in prolong

43 trophils have been shown to efficiently kill Cryptococcus neoformans, a causative agent of meningoenc

44 Human infection with Cryptococcus neoformans, a common fungal pathogen, follo

45 This is particularly true for Cryptococcus neoformans, a human fungal pathogen that ca

46 Here, we demonstrate that Cryptococcus neoformans, a model eukaryotic pathogen, re

47 One such organism is Cryptococcus neoformans, a pathogenic yeast that causes

48 It has shown potent activity against Cryptococcus neoformans, a yeast that can affect immunoc

49 The pathogenic fungus Cryptococcus neoformans additionally anchors its polysac

50 Cryptococcus neoformans admissions were not seasonal, an

51 es for melanization of the pathogenic fungus Cryptococcus neoformans also offers unique opportunities

52 ulates not only mating but also virulence in Cryptococcus neoformans, an opportunistic human pathogen

53 the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp.

54 of the relative contributions of individual Cryptococcus neoformans and Bacillus anthracis virulence

55 Aspergillus fumigatus, Alternaria alternata, Cryptococcus neoformans and Candida albicans) proteins w

56 e of macrophage autophagy in the response to Cryptococcus neoformans and Candida albicans, two import

57 nse against two prototypic fungal pathogens, Cryptococcus neoformans and Candida albicans.

58 Cryptococcus neoformans and Cryptococcus gattii are clos

59 Cryptococcus neoformans and Cryptococcus gattii are clos

60 Fundamental niche prediction of Cryptococcus neoformans and Cryptococcus gattii in Europ

61 ompare the molecular genotypes of strains of Cryptococcus neoformans and Cryptococcus gattii isolated

62 Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii.

63 marily caused by two related fungal species: Cryptococcus neoformans and Cryptococcus gattii.

64 poxia-mimetic CoCl2 in the pathogenic fungus Cryptococcus neoformans and demonstrated that CoCl2 lead

65 rabidopsis thaliana, Caenorhabditis elegans, Cryptococcus neoformans and Drosophila melanogaster.

66 Rho-GDI homolog in the human fungal pathogen Cryptococcus neoformans and investigated its impact on p

67 erol endoperoxide, which were active against Cryptococcus neoformans and methicillin-resistance Staph

68 +) channel present in the plasma membrane of Cryptococcus neoformans and other fungi.

69 in GM-CSF are susceptible to infections with Cryptococcus neoformans and other opportunistic fungi.

70 Upon phagocytosis of Cryptococcus neoformans and polystyrene beads, CD63 was

71 AD-box RNA helicase in the pathogenic fungus Cryptococcus neoformans and proposes novel roles for thi

72 pase C1 (ISC1) gene from the fungal pathogen Cryptococcus neoformans and showed that it encodes an en

73 The fungal pathogens Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus have

74 sential for virulence of the fungal pathogen Cryptococcus neoformans, and bacterial P5CDHs have been

75 heromone responses, mating, and virulence in Cryptococcus neoformans, and it also reiterates that the

76 hly active against a second fungal pathogen, Cryptococcus neoformans, and moderately active against a

77 ntamoeba histolytica, Trichomonas vaginalis, Cryptococcus neoformans, and Saccharomyces cerevisiae us

78 Cryptococcus gattii and Cryptococcus neoformans are causal agents of cryptococco

79 ive T cell responses to the pathogenic yeast Cryptococcus neoformans are dependent on heavily mannosy

80 However, pathogenic strains of the fungus Cryptococcus neoformans are resistant to MBL binding.

81 gh activity toward Aspergillus fumigatus and Cryptococcus neoformans at acidic pH, yet remained nonto

82 e infections with pathogenic species such as Cryptococcus neoformans Because the purine biosynthesis

83 Infection with Cryptococcus neoformans begins when desiccated yeast cel

84 se, and catalytically dead Tps2PD(D24N) from Cryptococcus neoformans bound to trehalose-6-phosphate (

85 can is a major component of the cell wall of Cryptococcus neoformans, but its function has not been i

86 ved (Blastomyces dermatitidis by culture and Cryptococcus neoformans by PLEX-ID).

87 The human pathogenic fungus Cryptococcus neoformans can form biofilms on polystyrene

88 Upon ingestion by macrophages, Cryptococcus neoformans can survive and replicate intrac

89 rated that the opportunistic fungal pathogen Cryptococcus neoformans can synthesize authentic immunom

90 hree common systemic human fungal pathogens--Cryptococcus neoformans, Candida albicans and Aspergillu

91 Cryptococcus neoformans capsular glucuronoxylomannan (GX

92 ificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and foun

93 Cryptococcus neoformans capsular polysaccharides glucuro

94 Cryptococcus neoformans causes life-threatening meningit

95 Cryptococcus neoformans causes life-threatening meningoe

96 The opportunistic yeast Cryptococcus neoformans causes serious disease in humans

97 Cryptococcus neoformans causes severe, and often fatal,

98 xin, Srx1, in oxidative stress resistance of Cryptococcus neoformans causing fungal meningoencephalit

99 (MAbs) labeled with alpha-emitter 213Bi and Cryptococcus neoformans cells as well as between 213Bi-1

100 As in Cryptococcus neoformans, cellular trehalose was reduced

101 Cryptococcus neoformans (Cn) is a common facultative int

102 Cryptococcus neoformans (Cn) is a deadly fungal pathogen

103 Cryptococcus neoformans (Cn) is an encapsulated yeast th

104 tudies, we showed that the pathogenic fungus Cryptococcus neoformans (Cn) produces a specific and uni

105 dismutases (SODs) in the encapsulated yeast Cryptococcus neoformans (Cn) variety gattii to analyse t

106 iodiomycete forming an induced DOPA-melanin, Cryptococcus neoformans (CN); and the slow-growing envir

107 fungal activity against Candida albicans and Cryptococcus neoformans comparable to amphotericin B and

108 On Cryptococcus neoformans, configuring Conrad to reproduce

109 D82 showed rapid and specific recruitment to Cryptococcus neoformans-containing phagosomes compared t

110 ith Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma ca

111 Molecular types of the Cryptococcus neoformans/Cryptococcus gattii species comp

112 an parechovirus, varicella-zoster virus, and Cryptococcus neoformans/Cryptococcus gattii We describe

113 The role of B cells in resistance to Cryptococcus neoformans disease (i.e., cryptococcosis) i

114 aride capsule of the human pathogenic fungus Cryptococcus neoformans elicit diverse effects on fungal

115 The human fungal pathogen Cryptococcus neoformans encodes many Cu-responsive genes

116 The immune response to Cryptococcus neoformans following pulmonary infection of

117 Cryptococcus neoformans frequently causes fungal meningi

118 e expulsion of the lethal endosomal pathogen Cryptococcus neoformans from mammalian macrophages, also

119 Eumelanins produced by pathogenic Cryptococcus neoformans fungi are virulence factors that

120 he pathogenicity of a human fungal pathogen, Cryptococcus neoformans, GCS1 is not required for the pa

121 bservation of the altered pathogenicity of a Cryptococcus neoformans glucosylceramide (GlcCer) mutant

122 evealed apparent specificity differences for Cryptococcus neoformans glucuronoxylomannan (GXM).

123 The average mass of Cryptococcus neoformans GXM from four antigenically diff

124 ed the role of a Th2 bias in pathogenesis of Cryptococcus neoformans H99 infection by comparing inhal

125 The human pathogenic fungus Cryptococcus neoformans has a distinctive polysaccharide

126 The human pathogenic fungus Cryptococcus neoformans has a large polysaccharide capsu

127 Furthermore, Cryptococcus neoformans has become a primary human patho

128 The fungus Cryptococcus neoformans has emerged as a major cause of

129 n of clinically significant Candida species, Cryptococcus neoformans, Histoplasma capsulatum, and Bla

130 nistic fungal pathogens Candida albicans and Cryptococcus neoformans However, the molecular mechanism

131 ction with the opportunistic fungal pathogen Cryptococcus neoformans; however, the role of plasmacyto

132 Here, we show that a Cryptococcus neoformans Hsp70 homologue Ssa1 acts as a D

133 Recent studies in the pathobiology of Cryptococcus neoformans identified the presence of a fun

134 e mAbs to the capsule of the fungal pathogen Cryptococcus neoformans impaired yeast budding by trappi

135 Persistent pulmonary infection with Cryptococcus neoformans in C57BL/6 mice results in chron

136 The burden of Cryptococcus neoformans in cerebrospinal fluid (CSF) pre

137 he development of the protective response to Cryptococcus neoformans in mice with cryptococcal pneumo

138 ts for different levels of susceptibility to Cryptococcus neoformans in the mouse infection model.

139 (DC) have been shown to phagocytose and kill Cryptococcus neoformans in vitro and are believed to be

140 However, it is not known if Cryptococcus neoformans-induced changes in lung function

141 CBA/J mice with low-level persistent Cryptococcus neoformans infection had CD4+ T cells of ef

142 Experimental pulmonary Cryptococcus neoformans infection in BALB/c mice is asso

143 arization of T cells during murine pulmonary Cryptococcus neoformans infection in the secondary lymph

144 Therapeutic practices for Cryptococcus neoformans infection in transplant recipien

145 Pulmonary Cryptococcus neoformans infection of C57BL/6 mice is an

146 Using a mouse model of ABPM caused by Cryptococcus neoformans infection of C57BL/6 mice, the g

147 e highly susceptible to intratracheal (i.t.) Cryptococcus neoformans infection relative to BALB/c mic

148 ing the risk of dissemination and outcome of Cryptococcus neoformans infection were assessed in 111 o

149 cterium tuberculosis, Toxoplasma gondii, and Cryptococcus neoformans infection, implicating inflammat

150 The pathogenic fungus Cryptococcus neoformans infects humans upon inhalation a

151 tes transmigration of the neurotropic fungus Cryptococcus neoformans into the brain parenchyma after

152 The mechanisms by which Cryptococcus neoformans invades the brain are largely un

153 The mechanism by which Cryptococcus neoformans invades the central nervous syst

154 Cryptococcus neoformans is a basidiomycete fungus that i

155 The fungal meningitis pathogen Cryptococcus neoformans is a central driver of mortality

156 The encapsulated fungus Cryptococcus neoformans is a common cause of life-threat

157 Lethal disease caused by the fungus Cryptococcus neoformans is a consequence of the combined

158 Cryptococcus neoformans is a facultative intracellular f

159 Cryptococcus neoformans is a facultative intracellular o

160 Cryptococcus neoformans is a facultative intracellular p

161 Cryptococcus neoformans is a fatal fungal pathogen of hu

162 Cryptococcus neoformans is a fungal pathogen causing pul

163 Cryptococcus neoformans is a fungal pathogen that causes

164 Cryptococcus neoformans is a fungal pathogen that causes

165 Cryptococcus neoformans is a fungal pathogen that causes

166 Cryptococcus neoformans is a fungal pathogen that encoun

167 Cryptococcus neoformans is a fungal pathogen with a uniq

168 Cryptococcus neoformans is a fungal pathogen with worldw

169 Cryptococcus neoformans is a globally distributed human

170 Cryptococcus neoformans is a human fungal pathogen that

171 Cryptococcus neoformans is a human fungal pathogen that

172 Cryptococcus neoformans is a human fungal pathogen that

173 Cryptococcus neoformans is a human fungal pathogen that

174 The basidiomycete fungus Cryptococcus neoformans is a leading cause of AIDS-relat

175 The fungus Cryptococcus neoformans is a leading cause of mortality

176 Cryptococcus neoformans is a major cause of fungal menin

177 Cryptococcus neoformans is a neurotropic fungal pathogen

178 Cryptococcus neoformans is a pathogenic fungus responsib

179 Cryptococcus neoformans is a pathogenic yeast that can i

180 Cryptococcus neoformans is a pathogenic yeast that cause

181 The polysaccharide capsule of Cryptococcus neoformans is a powerful activator of the c

182 The encapsulated yeast Cryptococcus neoformans is a significant cause of mening

183 Cryptococcus neoformans is a significant fungal pathogen

184 Cryptococcus neoformans is a soil-dwelling fungus that c

185 Cryptococcus neoformans is a ubiquitous fungus that can

186 Cryptococcus neoformans is a ubiquitous, opportunistic f

187 The basidiomycetous fungal pathogen Cryptococcus neoformans is adapted to survive challenges

188 The SREBP ortholog in the pathogenic fungus Cryptococcus neoformans is also activated by high levels

189 Cryptococcus neoformans is an encapsulated fungal pathog

190 Cryptococcus neoformans is an encapsulated fungal pathog

191 Cryptococcus neoformans is an encapsulated human-pathoge

192 Cryptococcus neoformans is an encapsulated opportunistic

193 Cryptococcus neoformans is an environmental pathogen req

194 Cryptococcus neoformans is an important human, fungal pa

195 Cryptococcus neoformans is an opportunistic fungal patho

196 Cryptococcus neoformans is an opportunistic fungal patho

197 Cryptococcus neoformans is an opportunistic fungal patho

198 Cryptococcus neoformans is an opportunistic fungal patho

199 Cryptococcus neoformans is an opportunistic fungal patho

200 Cryptococcus neoformans is an opportunistic fungal patho

201 Cryptococcus neoformans is an opportunistic fungal patho

202 Cryptococcus neoformans is an opportunistic fungal patho

203 Cryptococcus neoformans is an opportunistic human pathog

204 Cryptococcus neoformans is an opportunistic pulmonary fu

205 Cryptococcus neoformans is an unconventional dimorphic f

206 ity to progressive infection with the fungus Cryptococcus neoformans is associated with an allergic p

207 pulmonary infection with the fungal pathogen Cryptococcus neoformans is associated with the accumulat

208 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans is associated with the CCR2-medi

209 The fungus Cryptococcus neoformans is currently the fourth greatest

210 Cryptococcus neoformans is ecologically widespread and a

211 the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether

212 Although Cryptococcus neoformans is recognized for its ability to

213 The opportunistic yeast Cryptococcus neoformans is surrounded by a polysaccharid

214 Cryptococcus neoformans is the leading cause of death by

215 Cryptococcus neoformans is the most common cause of adul

216 Cryptococcus neoformans is the only encapsulated human-p

217 The manifestation of virulence traits in Cryptococcus neoformans is thought to rely on intracellu

218 hannel from the model human fungal pathogen, Cryptococcus neoformans, is directly activated by the de

219 mune response against the pathogenic fungus, Cryptococcus neoformans, is unknown.

220 9%) Candida tropicalis isolates and 1 (2.4%) Cryptococcus neoformans isolate.

221 andida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infe

222 es, 15 isolates of the Zygomycetes order, 10 Cryptococcus neoformans isolates, 8 Rhodotorula isolates

223 C. glabrata, and 53 C. krusei isolates), 35 Cryptococcus neoformans isolates, and 191 other clinical

224 andida isolates, 73 Aspergillus isolates, 53 Cryptococcus neoformans isolates, and 25 other fungal is

225 Compared to Cryptococcus neoformans, little is known about the virul

226 e fungal pathogens Aspergillus fumigatus and Cryptococcus neoformans, little was known about their in

227 Pathogens included Balamuthia mandrillaris, Cryptococcus neoformans, lymphocytic choriomeningitis vi

228 Isavuconazole showed good activities against Cryptococcus neoformans (MIC90, 0.12 mug/ml) and other n

229 Numerous virulence factors expressed by Cryptococcus neoformans modulate host defenses by promot

230 rable to infection by the encapsulated yeast Cryptococcus neoformans Most commonly found in the envir

231 The pathogenic fungus Cryptococcus neoformans must adapt to glucose-limited co

232 The pathogenic fungus Cryptococcus neoformans must overcome multiple stressors

233 In previous studies we showed that a Cryptococcus neoformans mutant lacking glucosylceramide

234 of 1201 signature-tagged deletion strains of Cryptococcus neoformans mutants to identify previously u

235 s presenting with P. marneffei (n = 719) and Cryptococcus neoformans (n = 1598) infection to the Hosp

236 In the pathogenic fungus Cryptococcus neoformans, noncanonical Gbeta Gib2 promote

237 Macrophages ingest the fungus Cryptococcus neoformans only in the presence of opsonins

238 The Cryptococcus neoformans polysaccharide capsule is a well

239 xylomannan (GXM), the major component of the Cryptococcus neoformans polysaccharide capsule, hydrolyz

240 b, and IgG3 with a 12-mer peptide mimetic of Cryptococcus neoformans polysaccharide revealed a stoich

241 The fungus Cryptococcus neoformans possesses a polysaccharide capsu

242 The pathogenic fungus Cryptococcus neoformans produces PGE2, and we found that

243 aride capsule of the human pathogenic fungus Cryptococcus neoformans promotes opsonization but also i

244 Urease, a major virulence factor for Cryptococcus neoformans, promotes lethal meningitis/ence

245 gulatory networks in human pathogens such as Cryptococcus neoformans provides insights into host-path

246 The cell wall of pathogenic fungi such as Cryptococcus neoformans, provides a formidable barrier t

247 on and analysis of SRP in the human pathogen Cryptococcus neoformans, providing the first description

248 he major human opportunistic fungal pathogen Cryptococcus neoformans, remains unknown.

249 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires a T1 adaptive immune re

250 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires the development of T1-t

251 The basidiomycete fungal pathogen Cryptococcus neoformans requires the PUF protein, Pum1,

252 Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans, result in more deaths annually

253 iable tests that discriminate C. gattii from Cryptococcus neoformans (serotypes A, D, and AD).

254 meningoencephalitis-causing fungal pathogen Cryptococcus neoformans, sexual development leads to the

255 In Cryptococcus neoformans, sexual reproduction occurs thro

256 Structurally, the Cryptococcus neoformans Sp1 (Cn Sp1) protein was found t

257 In Cryptococcus neoformans, sphingolipid-derived diacylglyc

258 of C57BL/6 mice with the moderately virulent Cryptococcus neoformans strain 52D models the complex ad

259 murine model of C57BL/6J mice infected with Cryptococcus neoformans strain 52D.

260 s in mice given a pulmonary infection with a Cryptococcus neoformans strain engineered to produce the

261 ential of these genes by comparing wild-type Cryptococcus neoformans strain H99 with deletant and com

262 of interferon-gamma transgene expression by Cryptococcus neoformans strain H99gamma in abrogating al

263 oducibility strains (4 Candida species and 6 Cryptococcus neoformans strains), and 746 isolates of Ca

264 otective immune responses to highly virulent Cryptococcus neoformans strains, such as H99, are associ

265 Cryptococcus neoformans, the causative agent of cryptoco

266 pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage organism Zygo

267 In the human fungal pathogen Cryptococcus neoformans, the homeodomain transcription f

268 Cryptococcus neoformans, the most common cause of fungal

269 Cryptococcus neoformans, the predominant etiological age

270 In the human fungal pathogen Cryptococcus neoformans, the Rim101 protein retains cons

271 In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is im

272 in plants and animals, but in fungi such as Cryptococcus neoformans they are also associated with vi

273 In the human fungal pathogen Cryptococcus neoformans, three G protein alpha subunits

274 bilities of 110 isolates of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin,

275 nase Ste20, allows the human fungal pathogen Cryptococcus neoformans to grow at high temperature.

276 In order for Cryptococcus neoformans to invade the central nervous sy

277 ability of the opportunistic fungal pathogen Cryptococcus neoformans to resist oxidative stress is on

278 rcular (Histoplasma capsulatum) to punctate (Cryptococcus neoformans) to labeling at the bud sites (C

279 ignalling pathways to the basal tolerance of Cryptococcus neoformans towards fluconazole, the widely

280 that in the pathogenic basidiomycetous yeast Cryptococcus neoformans, two Galpha subunits (Gpa2, Gpa3

281 Cryptococcus neoformans typically grows in a yeast-like

282 The human-pathogenic fungus Cryptococcus neoformans undergoes phenotypic switching i

283 The basidiomycetous human fungal pathogen Cryptococcus neoformans uniquely uses the stress-activat

284 Most cases of cryptococcosis are caused by Cryptococcus neoformans var. grubii (serotype A), which

285 Cryptococcus neoformans var. grubii is the causative age

286 Compared to other well-studied Cryptococcus neoformans virulence factors such as the po

287 Cryptococcus neoformans was first described as a human f

288 cies/organism groups were isolated, of which Cryptococcus neoformans was the most common (31.2% of al

289 Using the yeast Cryptococcus neoformans, we describe a mechanism by whic

290 ns, Candida krusei, Candida parapsilosis and Cryptococcus neoformans were investigated.

291 f a human pathogen and basidiomycetous yeast Cryptococcus neoformans were investigated.

292 r understanding Ab-mediated immunity against Cryptococcus neoformans, where the different isotypes ma

293 or virulence factor of the pathogenic fungus Cryptococcus neoformans, which afflicts both immunocompe

294 sis is important for virulence of the fungus Cryptococcus neoformans, which can cause lethal meningoe

295 Cryptococcus neoformans, which causes fatal infection in

296 ypic diversity in the human pathogenic yeast Cryptococcus neoformans, which is globally distributed a

297 ave directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infecte

298 ) exhibit potent antifungal activity against Cryptococcus neoformans with high selectivity.

299 of lipid droplets during the interaction of Cryptococcus neoformans with macrophages in the presence

300 vestigated the outcome of the interaction of Cryptococcus neoformans with murine macrophages using la